ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0093

Overexpression of Epidermal Ifnk Promotes Systemic CD8+ T Cell Maturation After UV-exposure

Benjamin Klein1, Kelsey E. McNeely2, Debbie Colesa2, Yiqing Gao2, Nguyen Thi Kim Nguyen2, Johann Gudjonsson1 and J. Michelle Kahlenberg1, 1University of Michigan, Ann Arbor, MI, 2University of Michigan Michigan Medicine, Ann Arbor, MI

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Dermatology, interferon, Systemic lupus erythematosus (SLE), T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SLE – Animal Models Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Skin involvement is the most common organ manifestation in systemic lupus erythematosus (SLE), and exacerbation of cutaneous lupus (CLE) can precede systemic disease flares. Keratinocyte-derived interferon kappa (IFN-κ) is an important mediator of photosensitive responses in SLE and is chronically overexpressed in SLE non-lesional skin. However, the effects of a type I IFN-rich epidermis on immune system activation after UV is not well understood and might be crucial to understand UV-driven disease flares in SLE. Here, we explored responses to chronic UV exposure in vivo using a mouse model of overexpression of epidermal Ifnk.

Methods: We compared female 12-week-old BALB/c mice that overexpress Ifnk in the epidermis (TG) with BALB/c wild-type mice (WT) and assessed local and systemic immune responses at baseline and after UVB exposure. Mice were shaved, then irradiated with 200mJ/cm2 for 3 days per week for 2 weeks and observed for 2 weeks after irradiation. Cutaneous lesion size, proteinuria, and peripheral blood count were measured. Skin-draining lymph nodes were examined for T cell activation. Flow cytometry on splenocytes was performed to phenotype myeloid, T cells, and B cells.

Results: At baseline, both WT and TG mice were without skin lesions, proteinuria, or abnormalities in peripheral blood counts. After UVB exposure, both TG and WT mice developed cutaneous lesions that healed completely during the observation period post-irradiation. Peripheral blood counts revealed slight increases in monocytes in TG compared to WT mice after UVB exposure. Strikingly, TG mice showed higher T cell activation (CD69) in the spleen than WT post-UVB treatment. This was accompanied by a significant shift of naïve CD8+ T cells (CD62L+CD44–) towards effector CD8+ T cells (CD62L–CD44+) in TG compared to WT mice post-UVB treatment. B cell phenotyping revealed a similar abundance of naïve and switched GL7+ and plasma cells in both strains at baseline and post-UV. Similar increases in CD8+ T cell activation were seen in the draining lymph nodes in UV-exposed TG vs. WT mice, suggesting that CD8+T cell activation may spread from local to systemic in the context of chronic epidermal IFNs.

Conclusion: Our results identify a switch in the regulation of systemic T cell responses in the context of chronic epidermal type I IFN production. Further exploration will address which IFN-κ-induced factors are regulating these responses and further delineate the link between epidermal inflammation and disease flares in systemic lupus.

Supporting image 1

Figure 1. Overexpression of epidermal Ifnk promotes systemic T cell activation after UV exposure.
A) Experimental approach. Female WT and mice with overexpression of epidermal IFNk (IFNK Tg) were irradiated three days per week (UVB 300mJ/cm2) for two weeks and then observed for two more weeks. Peripheral blood, skin draining lymph nodes and spleens were harvested for immunophenotyping. B) Time course of number and size of skin lesions in WT and IFNK Tg mice after UVB irradiation (n=5). C) Peripheral blood counts before and after UV in female WT and IFNK Tg mice. D) Spleen gating strategy for T cells. E) Representative flow cytometry plots of splenic CD69+ CD8+ T cells and quantification of splenic CD69+ CD4+/CD8+ T cells in WT and IFNK Tg mice after UVB exposure. F) Representative flow cytometry plots and quantification of naive (CD62L+CD44-) and effector memory (CD62L-CD44+) CD4+/CD8+ T cells in WT and IFNK Tg mice before and after UV irradiation. Two-way ANOVA followed by Šídák’s multiple comparisons test, mean and SEM.


Disclosures: B. Klein: None; K. McNeely: None; D. Colesa: None; Y. Gao: None; N. Nguyen: None; J. Gudjonsson: AbbVie/Abbott, 12, support, Boehringer-Ingelheim, 12, support, Bristol-Myers Squibb(BMS), 12, support, Eli Lilly, 12, support, Janssen, 12, support, Novartis, 12, support; J. Kahlenberg: Amgen, 12, coauthor on publication, AstraZeneca, 2, Bristol-Myers Squibb(BMS), 2, 5, Eli Lilly, 2, Gilead, 2, GlaxoSmithKlein(GSK), 2, Janssen, 5.

To cite this abstract in AMA style:

Klein B, McNeely K, Colesa D, Gao Y, Nguyen N, Gudjonsson J, Kahlenberg J. Overexpression of Epidermal Ifnk Promotes Systemic CD8+ T Cell Maturation After UV-exposure [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/overexpression-of-epidermal-ifnk-promotes-systemic-cd8-t-cell-maturation-after-uv-exposure/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/overexpression-of-epidermal-ifnk-promotes-systemic-cd8-t-cell-maturation-after-uv-exposure/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology